1. |
Smith CH. Optic neuritis[M]//Miller NR, Newman NJ, Biousse V, et al. Walsh and Hoyt clinical neuro-ophthalmology. 6th ed. Baltimore:Lippincott Williams & Wilkins, 2005:293-326.
|
2. |
彭静婷, 张晓君, 崔世磊, 等. 儿童视神经炎病因分析[J]. 中华眼底病杂志, 2008, 24(2): 95-98.Peng JT, Zhang XJ, Cui SL, et al. Etiological study on optic neuritis in childhood[J]. Chin J Ocul Fundus Dis, 2008, 24(2): 95-98.
|
3. |
Banwell B, Bar-Or A, Arnold DL,et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study[J].Lancet Neurol, 2011, 10(5):436-445. DOI: 10.1016/S1474-4422(11)70045-X.
|
4. |
Absoud M, Lim MJ, Chong WK, et al. Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features[J]. MultScler, 2013, 19(1):76-86. DOI: 10.1177/1352458512445944.
|
5. |
Hintzen RQ, Dale RC, Neuteboom RF, et al.,Pediatric acquired CNS demyelinating syndromes: features associated with multiple sclerosis[J].Neurology, 2016, 87(9 Suppl 2):S67-73. DOI: 10.1212/WNL.0000000000002881.
|
6. |
Wingerchuk DM, Banwell B, Bennett JL, et al., International panel for NMO diagnosis: international consensus diagnostic criteria for neuromyelitis optica spectrum disorders[J]. Neurology,2015, 85(2):177-189. DOI: 10.1212/WNL.0000000000001729.
|
7. |
Ramanathan S, Dale RC, Brilot F. Anti-MOG antibody: the history, clinicalphenotype, and pathogenicity of a serum biomarker for demyelination[J]. Autoimmun Rev,2016, 15(4):307-324. DOI: 10.1016/j.autrev.2015.12.004.
|
8. |
Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders[J]. Neurology, 2014, 82(6):474-481. DOI: 10.1212/WNL.0000000000000101.
|
9. |
Waters P, Woodhall M, O'Connor KC, et al. MOG cell-based assay detects non-MS patients with inflammatory neurologic disease[J]. Neurol Neuroimmunol Neuroinflamm, 2015, 2(3):89. DOI: 10.1212/NXI.0000000000000089.
|
10. |
中华医学会眼科学分会神经眼科学组.视神经炎诊断和治疗专家共识(2014年)[J]. 中华眼科杂志, 2014, 50(6): 459-462.DOI: 10.3760/cma.j.issn.0412-4081.2014.06.013.Neuro-Ophthalmology Group, Ophthalmology Branch of Chinese Medical Association. Diagnosis and treatment guideline of optic neuritis (2014)[J]. Chin J Ophthalmol, 2014,50(6):459-462. DOI:10.3760/cma.j.issn.0412-4081.2014.06.013.
|
11. |
Kriss A, Francis DA, Cuendet F, et al.Recovery after optic neuritis in childhood[J]. J Neurol Neurosurg Psychiatry, 1988, 51(10):1253-1258.
|
12. |
Jo DH, Kim SJ, Chae JH, et al.The clinical characteristics of optic neuritis in Korean children[J]. Korean J Ophthalmol,2011,25 (2):116-120. DOI: 10.3341/kjo.2011.25.2.116.
|
13. |
Riikonen R. The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children[J]. Acta Neurol Scand, 1989, 8(5): 425-431.
|
14. |
Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized,controlled trial of corticosteroids in the treatment of acute optic neuritis[J]. N Engl J Med, 1992, 326 (9): 581-588.DOI: 10.1056/NEJM199202273260901.
|
15. |
Hwang JM, Lee YJ, Kim MK. Optic neuritis in Asian children[J]. J Pediatr Ophthalmol Strabismus, 2002, 39(1):26-32.
|
16. |
Morales DS, Siatkowski RM, Howard CW, et al. Optic neuritis in children[J]. J Pediatr Ophthalmol Strabismus, 2000, 37(5):254-259.
|
17. |
Mizota A, Niimura M, Adachi-Usami E.Clinical characteristics of Japanese children with optic neuritis[J]. Pediatr Neurol,2004,31 (1):42-45.DOI: 10.1016/j.pediatrneurol.2003.11.011.
|
18. |
Wilejto M, Shroff M, Buncic JR, et al. The clinical features,MRI findings, and outcome of optic neuritis in children[J]. Neurology, 2006,67 (2):258-262.DOI: 10.1212/01.wnl.0000224757.69746.fb.
|
19. |
Brady KM, Brar AS, Lee AG, et al. Optic neuritis in children: clinical features and visual outcome[J]. J AAPOS, 1999, 3(2):98-103.
|
20. |
Yeh EA, Graves JS, Benson LA, et al. Pediatric optic neuritis[J]. Neurology, 2016, 87(9 Suppl 2):S53-58. DOI: 10.1212/WNL.0000000000002822.
|